Pulliam, N. (2018). An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationPulliam, N. An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationPulliam, N. An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.